Safety and Immunogenicity of a Full-dose, Split-virion, Inactivated, Quadrivalent Influenza Vaccine in Healthy Children 6-35 Months of Age: A Randomized Controlled Clinical Trial

BACKGROUND: For children <3 years of age, a half dose of inactivated influenza vaccine (7.5 μg hemagglutinin per strain) has been used for more than 30 years, but several studies indicate that a full dose (15 μg hemagglutinin per strain) can be used in this population without increasing the rate...

Descripción completa

Detalles Bibliográficos
Autores principales: Robertson, Corwin A., Mercer, Monica, Selmani, Alexandre, Klein, Nicola P., Jeanfreau, Robert, Greenberg, David P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Williams & Wilkins 2019
Materias:
Vaccine Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437098/
https://www.ncbi.nlm.nih.gov/pubmed/30395011
http://dx.doi.org/10.1097/INF.0000000000002227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437098/
https://www.ncbi.nlm.nih.gov/pubmed/30395011
http://dx.doi.org/10.1097/INF.0000000000002227

Ejemplares similares